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Perspective
O
ver the past half century, 
one of the most familiar and 
effective arguments put forth 
by the tobacco industry to defend its 
business and minimise its regulation 
is that it generates net economic 
benefits to society. Put simply, 
industry advocates claim that taxation, 
profits, and employment associated 
with tobacco far outweigh any costs 
imposed on societies and in particular 
on health care systems. For decades, 
this argument has been trotted out in 
mantra-like fashion around the world 
whenever stronger tobacco control 
measures, such as higher taxation or 
market restrictions, are mooted. And 
by and large, governments have bought 
into the belief that tobacco control is 
simply unaffordable.
Closer Scrutiny of the Tobacco 
Balance Sheet
Beginning in the mid-1980s, public 
health researchers began to apply 
economic methods in an attempt to 
challenge industry claims. In his 1986 
paper “Economics and Cigarettes”, 
Thomas Schelling (winner of the 
2005 Nobel Prize for economics) 
applied the economic concept of an 
“accounting framework”, comprising 
such elements as lost lives, lost 
livelihoods, excise taxes, costs of 
regulating smoking behaviours, 
and medical costs, to assessing 
the economic impacts of tobacco 
production and consumption [1]. 
This early work encouraged a broader 
view of the real costs of smoking. 
Joy Townsend used microeconomics 
to support the adoption of pricing 
mechanisms to regulate tobacco use, 
showing, for example, that progressive 
increases in cigarette tax rates are 
powerful means of changing individual 
behaviour (namely reducing cigarette 
consumption) while generating extra 
government revenue [2]. Examining 
the macroeconomics of tobacco, 
Kenneth Warner and George Fulton 
highlighted the industry’s strategy 
of inflating its accrued benefits, 
while downplaying certain economic 
activities (such as the services of 
health care workers and undertakers) 
that highlight the undesirable 
consequences of tobacco [3]. As part 
of the negotiation process for the 
Framework Convention on Tobacco 
Control (FCTC), economic analysis 
of tobacco was extended to the global 
level. Howard Barnum’s 1994 study 
of the economic burden of the global 
trade in tobacco [4], later joined by the 
work of Frank Chaloupka, Prabhat Jha, 
and others [5], proved instrumental to 
garnering support for the FCTC, not 
only by further undermining industry 
claims of the net economic benefits 
from tobacco, but because of its 
support and publication by the World 
Bank. This shift in stance by the World 
Bank, better known in the past for 
funding rather than opposing tobacco 
production, provided the World Health 
Organization with a key political ally.
Tobacco Control as Sound 
Investment
In the August 2008 issue of PLoS
Medicine, Stanton Glantz and 
colleagues add another dimension 
to this important body of work on 
the economics of tobacco by showing 
that investment in tobacco control 
programmes leads to substantial savings 
in health care expenditures [6]. This 
new evidence undermines another 
pillar of the industry’s longstanding 
argument that tobacco control is 
a waste of public monies. On the 
contrary, the authors show that the 
US$1.8 billion spent on California’s 
tobacco control programme over 15 
years (1989–2004) has yielded a 50-fold 
return (US$86 billion) in reduced 
health care costs. As well as effectively 
reducing smoking—a significant public 
health goal in itself—the benefits of the 
programme include “substantial, rapid, 
and growing reductions in per capita 
state health care expenditures.”
The authors point out that the 
nature of the programme’s activities, 
alongside sustained levels of 
appropriate funding, was an important 
factor in its success. In California, 
tobacco control messages were targeted 
at the general population (as opposed 
to youth prevention), resulting in 
more immediate effects on cessation 
and associated morbidity. This finding 
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Linked Research Article
This Perspective discusses the 
following new study published in PLoS
Medicine:
Lightwood JM, Dinno A, Glantz SA 
(2008) Effect of the California Tobacco 
Control Program on personal health 
care expenditures. PLoS Med 5(8): e178. 
doi:10.1371/journal.pmed.0050178
Stanton Glantz and colleagues find 
that the California state tobacco control 
program is associated not only with 
reduced smoking, but with reductions in 
health care costs as well.PLoS Medicine  |  www.plosmedicine.org 1309 September 2008  |  Volume 5  |  Issue 9  |  e189
is important at a time when tobacco 
companies have aggressively promoted 
their own “youth smoking education 
and prevention” programmes 
worldwide, designed as flagships 
for corporate social responsibility 
initiatives and with dubious intent [7]. 
Moreover, a key focus of the California 
programme’s work was changing social 
norms, particularly the raising of public 
support for smoke-free environments. 
Smoking has become increasingly 
socially unacceptable, strengthening 
behavioural change, compliance, and 
public self-regulation.
The relevance of these lessons—the 
need for increased and consistent 
public funding and broadly targeted 
activities—go far beyond California. In 
other US states, despite large sums of 
money derived from tobacco taxation 
and legal settlements, relatively little 
of these funds have been invested in 
tobacco control. This has been the 
case especially where pressures on 
public spending cause the diversion 
of funds elsewhere. Globally, the 
US$1.8 billion spent in California on 
tobacco control, averaging US$120 
million annually or US$3.29 per 
capita (based on California’s 2006 
population of around 36.5 million), 
dwarfs the budgets of most national 
tobacco control programmes. In a 
survey of 30 European countries, 
Joossens and Raw found that tobacco 
control programme budgets for 2006 
ranged from  238,215 (US$371,000) 
or US$0.01 per capita for Romania, to 
 108,196,235 (US$168.5 million) or 
US$2.79 per capita for England [8]. 
The World Health Organization’s 2008 
Report on the Global Tobacco Epidemic 
similarly estimates that tobacco control 
is grossly underfunded, notably in 
low- and middle-income countries [9]. 
(One exception is Thailand, where 
the Thai Health Promotion Office, an 
autonomous state agency, is funded 
by 2% of alcohol and tobacco taxes, 
amounting to around US$35 million 
annually [10].) These are alarming 
statistics, given the rapid shift in the 
tobacco pandemic to the developing 
world, where 70% of the predicted 
10 million annual tobacco deaths by 
2030 will occur (see the figure on the 
underfunding of global tobacco control 
on page 57 of [9]). 
As well as challenging industry 
claims that tobacco is a necessary 
economic evil, therefore, Glantz and 
colleagues raise questions about the 
spending priorities of governments on 
public health. As tobacco is the leading 
cause of premature death and disease, 
responsible for 5.4 million deaths 
each year [9], it is an anachronism 
that tobacco control programmes 
still remain among the most poorly 
funded. Donor agencies are equally 
culpable. While the FCTC pushed 
tobacco control far higher on national 
and global policy agendas than ever 
before, concrete commitments to 
implement the wide-ranging provisions 
of the treaty have been disappointingly 
lacklustre. Implementation, especially 
in low- and middle-income countries, 
remains handicapped by a lack of 
resources. As the tobacco industry 
itself has become fond of arguing, 
low- and middle-income countries 
have other priorities, such as HIV/
AIDS, tuberculosis, and malaria, which 
demand the immediate attention of 
policy makers. Most political systems 
remain more attuned to acute rather 
than longer-term needs, even if 
the latter eventually cause greater 
burdens of death and disease. Yet, 
as this new research by Glantz and 
colleagues shows, substantial returns 
are both immediate and long-term. 
The announcement in July of New 
York City mayor Michael Bloomberg’s 
Global Initiative to Reduce Tobacco 
Use, which includes a combined 
commitment of US$500 million to 
“help governments in developing 
countries implement proven policies 
and increase funding for tobacco 
control” [11], is an important step in 
correcting the longstanding imbalance 
in costs and benefits from tobacco 
use. Funding of this magnitude, as 
Glantz and colleagues demonstrate, 
can be a sound investment that rapidly 
and significantly reduces health care 
expenditure and saves valuable human 
lives.  
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